MedTrace Logo

Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers

NCT02900079 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-09-28

No results posted yet for this study

Summary

This study is part of a larger prospective cohort study (JOKA), designed to study the incidence and etiological spectrum of febrile illness occurring during a travel to the tropics, as well as clinical course, care, treatment and outcome of these febrile illness episodes. Its objective is to evaluate the clinical use of malaria rapid diagnostic tests (RDT) by travelers or their peers during travel, as a decision aid for the management of febrile illness in the tropics.

If the study demonstrates that malaria can be ruled out safely by travelers themselves using a RDT, a combination of self/peer testing with SBET may become an alternative to antimalarial chemoprophylaxis in travel medicine.

Conditions

Interventions

DEVICE

rapid diagnostic test for malaria antigen

rapid diagnostic test for malaria antigen to be used by travelers when febrile

Sponsors & Collaborators

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Jan Jacobs, MD PhD · Institute of Tropical Medicine, Antwerp, Belgium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02900079 on ClinicalTrials.gov